Jia Minghui, Chen Zhongchun, Guo Yongwei, Chen Xin, Zhao Xia
Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou.
Department of Otolaryngology-Head and Neck Surgery, Huashan Hospital, Fudan University.
Int J Nanomedicine. 2017 Apr 10;12:2933-2939. doi: 10.2147/IJN.S130160. eCollection 2017.
biofilms contribute significantly to the recalcitrant nature of chronic rhinosinusitis. In previous studies, it has been shown that silk fibroin-nano silver solution can eliminate biofilms in vitro, which suggests a potential role of this novel agent in the treatment of biofilm-associated diseases, such as sinusitis.
The aim of this study was to investigate the efficacy of silk fibroin-nano silver solution as a topical anti-biofilm agent in a rabbit model of sinusitis.
Biofilm-associated sinusitis models were established in 24 New Zealand White rabbits by gelatin sponge placement and inoculation through a hole drilled into the anterolateral wall of the right maxillary sinus. After 4 weeks, indwelling catheters were placed into the maxillary sinus. Different concentrations of silk fibroin-nano silver solution or normal saline were irrigated slowly into the maxillary sinus via the indwelling catheters. After 7 days of irrigation, the rabbits were sacrificed. The sinus mucosa was harvested and examined for biofilm biomass as well as morphological integrity of the epithelium by scanning electron microscopy.
Silk fibroin-nano silver solution was found to be most effective in reducing the biomass of the biofilms at a concentration of 384 mg/L, followed by the concentration of 153.6 mg/L, when compared with saline. After treatment with 384 mg/L silk fibroin-nano silver solution, the biofilms were completely eliminated and the injured epithelium was almost restored with regenerated cilia on the surface.
Silk fibroin-nano silver solution was found to be an effective topical agent against biofilms in the rabbit model of sinusitis, and its effect was concentration-dependent.
生物膜对慢性鼻窦炎的顽固性有显著影响。在先前的研究中,已表明丝素蛋白-纳米银溶液可在体外消除生物膜,这提示该新型制剂在治疗生物膜相关疾病(如鼻窦炎)中具有潜在作用。
本研究旨在探讨丝素蛋白-纳米银溶液作为局部抗生物膜剂在兔鼻窦炎模型中的疗效。
通过在上颌窦前外侧壁钻孔并植入明胶海绵,对24只新西兰白兔建立生物膜相关性鼻窦炎模型。4周后,将留置导管置入上颌窦。通过留置导管将不同浓度的丝素蛋白-纳米银溶液或生理盐水缓慢灌注入上颌窦。灌注7天后,处死兔子。采集鼻窦黏膜,通过扫描电子显微镜检查生物膜生物量以及上皮的形态完整性。
与生理盐水相比,发现丝素蛋白-纳米银溶液在浓度为384 mg/L时对减少生物膜生物量最有效,其次是浓度为153.6 mg/L时。用384 mg/L丝素蛋白-纳米银溶液处理后,生物膜被完全消除,受损上皮几乎恢复,表面有再生的纤毛。
发现丝素蛋白-纳米银溶液在兔鼻窦炎模型中是一种有效的局部抗生物膜剂,其效果呈浓度依赖性。